In the News

Neuro Drugs are Still Faltering, Despite Rising Investment

July 29, 2024
Loading the Elevenlabs Text to Speech AudioNative Player...
28bio Launches CNS-3D Alzheimer’s Model to Predict Therapeutic Efficacy
The CNS-3D Induced Alzheimer’s Model is a brain organoid assay enabling researchers to evaluate whether therapeutic candidates can reduce or prevent disease progression in patients.
28bio Launches CNS-3D Inflammatory Organoids to Predict Anti-inflammatory Therapeutic Efficacy
The only assay-ready immunocompetent 3D brain organoid model incorporating microglia for studies of neuroinflammatory mechanisms and drug efficacy
28bio Launches CNS-3D Myelinated Organoids to Predict Therapeutic Efficacy
CNS-3D Myelinated Organoids are designed to quantify drug-induced demyelination, observe natural remyelination, and evaluate therapeutic strategies for myelin repair, capturing both injury and recovery within the same biological context.